131 results on '"Ryynanen, Markku"'
Search Results
2. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation
3. Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia
4. First Trimester Placental Retinol-Binding Protein 4 (RBP4) and Pregnancy-Associated Placental Protein A (PAPP-A) in the Prediction of Early-Onset Severe Pre-Eclampsia
5. Combined First-Trimester Screening in Northern Finland: Experiences of the First Ten Years
6. Dominant Dystrophic Epidermolysis Bullosa: Identification of a Gly → Ser Substitution in the Triple-Helical Domain of Type VII Collagen
7. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland
8. The significance of the second trimester sonographic soft markers in pregnancies after normal first trimester screening
9. Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland
10. COMBINING SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR1 (STNFR1) AND PREGNANCY ASSOCIATED PLA-CENTAL PROTEIN A (PAPP-A) WITH MATERNAL CHARACTERISTICS ARE USEFUL FOR FIRST TRIMESTER PREDICTION OF EARLY-ONSET PRE-ECLAMPSIA.
11. First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age
12. Natural history of familial myomas
13. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. (Report)
14. False-Negative Results in Routine Combined First-Trimester Screening for Down Syndrome in Finland
15. Screening and outcome of chromosomal abnormalities other than trisomy 21 in Northern Finland
16. More invasive procedures are done to detect each case of Downʼs syndrome in younger women
17. Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths
18. Prevalence of Downʼs syndrome in a pregnant population in Finland
19. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR
20. Familial intracranial aneurysms
21. Dominant dystrophic epidermolysis bullosa: identification of a Gly yielding Ser substitution in the triple-helical domain of type VII collagen
22. The Effects on Fetal Development of High alpha-Fetoprotein and Maternal Smoking
23. Fragile-X: Neuropsychological Test Performance, CGG Triplet Repeat Lengths, and Hippocampal Volumes
24. Fetus-Placenta-Newborn: Carrier diagnosis of the fragile X syndrome --A challenge in antenatal clinics
25. Carrier diagnosis of the fragile X syndrome - a challenge in antenatal clinics
26. Sequencing of cDNA from 50 Unrelated Patients Reveals That Mutations in the Triple-Helical Domain of Type III Procollagen Are an Infrequent Cause of Aortic Aneurysms
27. First trimester combined screening biochemistry in detection of congenital heart defects.
28. First trimester combined screening biochemistry in detection of congenital heart defects
29. Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland
30. Risk of Adverse Outcomes in Euploid Pregnancies With Isolated Short Fetal Femur and Humerus on Second‐Trimester Sonography
31. Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.
32. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations
33. A study of genetic linkage heterogeneity in adult polycystic kidney disease
34. Combination of PAPPA, fhCGβ, AFP, PIGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia
35. Extrauterine pregnancies-risk factors and management
36. Laparoscopic diagnosis of endometriosis—Clinical study
37. First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age
38. Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening
39. False-Negative Results in Routine Combined First-Trimester Screening for Down Syndrome in Finland
40. Maternal Serum ADAM12 Levels Correlate with PAPP-A Levels during the First Trimester
41. 659: First trimester maternal serum PAPP-A and F-HCG levels in singleton IVF pregnancies
42. 597: Maternal serum low PAPP-A in the first trimester is an independent risk factor for adverse pregnancy outcome
43. Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction
44. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency
45. Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: integration of gene tests and fetal karyotyping
46. Antenatal gene tests in low‐risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland
47. Pregnancy outcome in carriers of fragile X
48. Genome-wide linkage disequilibrium mapping of late onset Alzheimer's disease in Finland
49. Women's decision-making in prenatal screening
50. Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.